Fineotex Chemical Limited has informed the Exchange regarding a press release dated May 20, 2025, titled "Earning Update".
FCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fineotex Chemical Limited reported FY25 consolidated Total Income of ₹557.64 crore, down 4.76% from ₹585.51 crore in FY24. Gross Profit stood at ₹205.71 crore with a margin of 38.57% (marginally lower by 12 bps). EBITDA fell 14.26% to ₹127.23 crore with margin contracting by 222 bps to 23.85%. Profit After Tax (PAT) declined 9.77% to ₹109.21 crore, while PAT margin slipped to 20.48%. The company declared a total dividend of ₹0.80 per share, aggregating to ₹9.16 crore. Operationally, FCL added 30 new customers and developed 15 new products in Q4, received government approval for its biotechnology-based mosquito control solution AquaStrike Premium, and won multiple sustainability and quality certifications. The company's greenfield expansion adding 15,000 MTPA capacity (taking total to 1,20,000 MTPA) is on track for Q2 FY26 commissioning.
Short-term: The broad-based decline across revenue, EBITDA, and PAT may weigh on sentiment, though margins held relatively firm. Positive offset: dividend payout, new product approvals, capacity expansion, and the India-UK FTA tailwind for exports. Long-term: capacity addition, new business verticals (Water Treatment, Oil & Gas), and product diversification should support growth once commissioning and demand recovery kick in.